Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Amortizatization of Intangibles (2024 - 2025)

Silence Therapeutics' Amortizatization of Intangibles history spans 2 years, with the latest figure at $36000.0 for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 43.75% year-over-year to $36000.0; the TTM value through Dec 2025 reached $243000.0, down 5.45%, while the annual FY2025 figure was $243000.0, 5.45% down from the prior year.
  • Amortizatization of Intangibles for Q4 2025 was $36000.0 at Silence Therapeutics, down from $75000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $75000.0 in Q3 2025 and bottomed at $36000.0 in Q4 2025.